share_log

Dolby Laboratories Insider Lowered Holding By 100% During Last Year

Dolby Laboratories Insider Lowered Holding By 100% During Last Year

杜比實驗室內部人士去年將持股量降低了100%
Simply Wall St ·  03/12 07:27

Insiders were net sellers of Dolby Laboratories, Inc.'s (NYSE:DLB ) stock during the past year. That is, insiders sold more stock than they bought.

內部人士是杜比實驗室公司的淨賣家。”s(紐約證券交易所代碼:DLB)在過去一年的股票。也就是說,內部人士賣出的股票多於買入的股票。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.

儘管我們絕不會建議投資者僅根據公司董事的所作所爲做出決定,但我們認爲完全忽視內幕交易是愚蠢的。

The Last 12 Months Of Insider Transactions At Dolby Laboratories

杜比實驗室過去 12 個月的內幕交易

Over the last year, we can see that the biggest insider sale was by the Senior VP & Chief Marketing Officer, Todd Pendleton, for US$1.0m worth of shares, at about US$81.69 per share. That means that an insider was selling shares at slightly below the current price (US$83.83). We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. However, while insider selling is sometimes discouraging, it's only a weak signal. It is worth noting that this sale was 100% of Todd Pendleton's holding. Todd Pendleton was the only individual insider to sell shares in the last twelve months.

在過去的一年中,我們可以看到,最大的內幕出售是高級副總裁兼首席營銷官託德·彭德爾頓出售了價值100萬美元的股票,每股約81.69美元。這意味着一位內部人士正在以略低於當前價格(83.83美元)的價格出售股票。如果內部人士一直在賣出,特別是如果他們賣出低於當前價格,我們通常認爲這是負面的,因爲這意味着他們認爲較低的價格是合理的。但是,儘管內幕銷售有時令人沮喪,但這只是一個微弱的信號。值得注意的是,此次出售是託德·彭德爾頓持有的100%。託德·彭德爾頓是過去十二個月中唯一出售股票的內部人士。

Todd Pendleton sold a total of 13.98k shares over the year at an average price of US$82.00. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

託德·彭德爾頓全年共出售了13.98萬股股票,平均價格爲82.00美元。您可以看到下圖所示的去年的內幕交易(公司和個人)。如果你想確切地知道誰賣了、賣了多少以及何時出售,只需點擊下圖!

insider-trading-volume
NYSE:DLB Insider Trading Volume March 12th 2024
紐約證券交易所:DLB 內幕交易量 2024 年 3 月 12 日

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一樣,那麼你不會想錯過這份業內人士正在收購的成長型公司的免費名單。

Insiders At Dolby Laboratories Have Sold Stock Recently

杜比實驗室的內部人士最近出售了股票

Over the last three months, we've seen significant insider selling at Dolby Laboratories. In total, Senior VP & Chief Marketing Officer Todd Pendleton sold US$1.0m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.

在過去的三個月中,我們看到了杜比實驗室的大量內幕銷售。在此期間,高級副總裁兼首席營銷官託德·彭德爾頓總共出售了價值100萬美元的股票,我們沒有記錄任何購買記錄。有鑑於此,很難說所有內部人士都認爲股票很划算。

Insider Ownership Of Dolby Laboratories

杜比實驗室的內部所有權

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Dolby Laboratories insiders own about US$41m worth of shares. That equates to 0.5% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

測試公司領導者與其他股東之間一致性的另一種方法是查看他們擁有多少股份。通常,內部人士的所有權越高,內部人士長期建立公司的可能性就越大。杜比實驗室內部人士擁有價值約4100萬美元的股票。這相當於該公司的0.5%。儘管這是一個強勁但並不突出的內部所有權水平,但這足以表明管理層與小型股東之間有一定的一致性。

So What Do The Dolby Laboratories Insider Transactions Indicate?

那麼,杜比實驗室的內幕交易表明了什麼?

An insider hasn't bought Dolby Laboratories stock in the last three months, but there was some selling. Looking to the last twelve months, our data doesn't show any insider buying. But since Dolby Laboratories is profitable and growing, we're not too worried by this. While insiders do own shares, they don't own a heap, and they have been selling. So we'd only buy after careful consideration. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. In terms of investment risks, we've identified 1 warning sign with Dolby Laboratories and understanding it should be part of your investment process.

內部人士在過去三個月中沒有購買杜比實驗室的股票,但出現了一些拋售。展望過去的十二個月,我們的數據並未顯示任何內幕買盤。但是,由於杜比實驗室盈利且不斷增長,我們對此並不太擔心。儘管內部人士確實擁有股票,但他們並不擁有大量股票,他們一直在拋售。因此,我們只有在仔細考慮後才會購買。雖然我們喜歡了解內部人士的所有權和交易情況,但在做出任何投資決策之前,我們一定要考慮股票面臨的風險。在投資風險方面,我們已經向杜比實驗室確定了一個警告信號,並知道這應該是您投資過程的一部分。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

當然,通過尋找其他地方,你可能會找到一筆不錯的投資。因此,來看看這份有趣的公司的免費清單吧。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論